Loading...

iAnthus Capital Holdings, Inc.

IAN.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.005
CA$0.00(0.00%)

iAnthus Capital Holdings, Inc. (IAN.CN) Company Profile & Overview

Explore iAnthus Capital Holdings, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

iAnthus Capital Holdings, Inc. (IAN.CN) Company Profile & Overview

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEORichard Proud

Contact Information

646 518 9411
420 Lexington Avenue, Toronto, NY, 10170

Company Facts

716 Employees
IPO DateSep 7, 2016
CountryUS
Actively Trading

Frequently Asked Questions

;